Skip to search formSkip to main contentSkip to account menu

QVA149

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
BACKGROUND Three classes of inhaler medications are used to manage chronic obstructive pulmonary disease (COPD): long-acting beta… 
Highly Cited
2015
Highly Cited
2015
Background The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one… 
Highly Cited
2015
Highly Cited
2015
RATIONALE Current Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy recommends the combination of two long… 
Highly Cited
2013
Highly Cited
2013
We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its monocomponents indacaterol and… 
Highly Cited
2013
Highly Cited
2013
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and glycopyrronium, on direct patient-reported… 
Review
2012
Review
2012
Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). Long-acting muscarinic… 
Highly Cited
2010
Highly Cited
2010
ABSTRACT This study assessed the cardiovascular safety of QVA149, an inhaled, once daily, bronchodilator combination containing… 
Highly Cited
2010
Highly Cited
2010
Background This randomised, double-blind, placebo controlled, four-period crossover study assessed the efficacy and safety of…